Published

Current situation regarding psychedelics and magic mushroom in Korea

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: European Psychiatry
Date: 2024-04-01
Source: OpenAlex
DOI: 10.1192/j.eurpsy.2024.1695
PubMed: Unavailable

Authors

J. S. Seo

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety End-of-Life Distress Clinical Trial Review Article Cancer Patients Treatment-Resistant Depression Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Current situation regarding psychedelics and magic mushroom in Korea2024-04-01

Related papers

THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERSInternational Journal of Innovative Technologies in Social Science · 2026-01-22 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01